Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Cash from Financing Activities (2019 - 2026)

Nkarta (NKTX) posted quarterly Cash from Financing Activities of $6000.0 for Q1 2026, down 90.62% quarter-over-quarter from $64000.0 in Q4 2025.

Nkarta (NKTX) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Nkarta's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $6000.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $6000.0; the TTM figure through Mar 2026 stood at $147000.0 (up 180.77% YoY), while the FY2025 annual figure was $141000.0, down 99.94% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $6000.0, down from $64000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $226.3 million in Q1 2024, with the low at -$368000.0 in Q2 2024.
  • The 5-year median for Cash from Financing Activities is $131500.0 (2022), against an average of $31.9 million.
  • Peak annual rise in Cash from Financing Activities reached 22626500.0% in 2024, while the deepest fall reached 193.16% in 2024.
  • Nkarta's Cash from Financing Activities stood at $424000.0 in 2022, then tumbled by 30.42% to $295000.0 in 2023, then slumped by 37.63% to $184000.0 in 2024, then sank by 65.22% to $64000.0 in 2025, then slumped by 90.62% to $6000.0 in 2026.
  • Business Quant data shows NKTX's Cash from Financing Activities at $6000.0 in Q1 2026, $64000.0 in Q4 2025, and $77000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Nkarta 201.14 Mn 201.14 Mn - 676,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 676,000.00
Jun 30, 2026 676,000.00
Mar 31, 2026 6,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 64,000.00
Dec 31, 2025 64,000.00
Jun 30, 2025 77,000.00
Jun 30, 2025 77,000.00
Dec 31, 2024 184,000.00
Dec 31, 2024 184,000.00
Sep 30, 2024 2,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 -368,000.00
Jun 30, 2024 -368,000.00
Mar 31, 2024 226.27 Mn
Mar 31, 2024 226.27 Mn
Dec 31, 2023 295,000.00
Dec 31, 2023 295,000.00
Jun 30, 2023 395,000.00
Jun 30, 2023 395,000.00